RxSight, Inc. (RXST) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$12.77M*; Operating income -$13.77M; Depreciation and amortization $999.00K*.
- 2026-03-31: Basis Reported; EBITDA -$17M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$10.49M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$11.32M*; Operating income -$12.18M; Depreciation and amortization $854.00K*.
Complete source-backed ebitda history.
- Available history
- 2020-12-31 to 2026-03-31
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$12.77M* | -$13.77M | $999.00K* | $27.24M | -46.88%* | $1.96M* | -$9.54M* | $7.86M | $9.24M | $30.42M | $88.00K |
|---|
| 2026-03-31 | Reported | -$17M | (m) | (m) | (m) | -55.01% | $759.00K | -$10.89M | $7.39M | $9.47M | $31.86M | $6.00K |
|---|
| 2025-12-31 | Reported | -$10.49M | (m) | (m) | (m) | -32.16% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$11.32M* | -$12.18M | $854.00K* | $30.34M | -37.32%* | $581.00K* | -$1.19M* | $6.11M | $9.06M | $27.34M | $10.00K |
|---|
| 2025-06-30 | Reported | -$13.22M* | -$14.00M | $785.00K* | $33.64M | -39.30%* | $1.54M* | -$4.38M* | $8.45M | $10.22M | $28.98M | $32.00K |
|---|
| 2025-03-31 | Reported | -$9.9M | (m) | (m) | (m) | -26.12% | $575.00K | -$8.83M | $9.57M | $10.37M | $28.64M | $18.00K |
|---|
| 2024-12-31 | Reported | -$8.11M | (m) | (m) | (m) | -20.17% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | -$8.09M* | -$9.23M | $1.13M* | $35.31M | -22.92%* | $1.10M* | $650.00K* | $10.09M | $8.84M | $25.61M | $13.00K |
|---|
| 2024-06-30 | Reported | -$7.52M* | -$8.33M | $812.00K* | $34.89M | -21.56%* | $1.52M* | -$4.03M* | $10.64M | $8.29M | $24.29M | $16.00K |
|---|
| 2024-03-31 | Reported | -$9.56M | (m) | (m) | (m) | -32.38% | $1.97M | -$9.31M | $8.83M | $8.03M | $23.32M | $9.00K |
|---|
| 2023-12-31 | Reported | -$9.8M | (m) | (m) | (m) | -34.29% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | -$11.43M* | -$12.51M | $1.08M* | $22.20M | -51.48%* | $653.00K* | -$7.98M* | $8.47M | $7.10M | $19.14M | $12.00K |
|---|
| 2023-06-30 | Reported | -$12.64M* | -$13.63M | $989.00K* | $20.81M | -60.72%* | $1.82M* | -$7.55M* | $8.79M | $7.40M | $18.24M | $26.00K |
|---|
| 2023-03-31 | Reported | -$12.14M | (m) | (m) | (m) | -69.43% | $747.00K | -$17.76M | $7.12M | $7.21M | $16.25M | $0.00 |
|---|
| 2022-12-31 | Reported | -$14.07M | (m) | (m) | (m) | -87.47% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2022-09-30 | Reported | -$15.02M* | -$15.96M | $941.00K* | $12.62M | -119.04%* | $580.00K* | -$15.19M* | $7.26M | $6.39M | $14.93M | $0.00 |
|---|
| 2022-06-30 | Reported | -$14.78M* | -$15.79M | $1.01M* | $11.36M | -130.13%* | $1.08M* | -$14.82M* | $6.57M | $6.19M | $14.39M | $0.00 |
|---|
| 2022-03-31 | Reported | -$15.56M | (m) | (m) | (m) | -174.03% | $370.00K | -$14.98M | $5.18M | $6.72M | $13.62M | $4.00K |
|---|
| 2021-12-31 | Reported | -$13.64M | (m) | (m) | (m) | -161.86% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2021-09-30 | Reported | -$12.11M* | -$13.11M | $1.01M* | $5.79M | -209.23%* | $254.00K* | -$13.76M* | $4.45M | $5.38M | $9.08M | -$4.00K |
|---|
| 2021-06-30 | Reported | -$12.89M* | -$13.88M | $986.00K* | $4.90M | -263.24%* | $823.00K* | -$11.98M* | $5.71M | $6.56M | $6.50M | $3.00K |
|---|
| 2021-03-31 | Reported | -$10.18M | (m) | (m) | (m) | -292.11% | $498.00K | -$10.25M | $2.37M | $6.64M | $5.61M | $7.00K |
|---|
| 2020-12-31 | Reported | -$7.32M | (m) | (m) | (m) | -148.86% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2020-09-30 | Reported | -$7.87M* | -$8.91M | $1.03M* | $4.17M | -188.78%* | $603.00K* | -$6.95M* | $3.45M | $5.80M | $3.83M | $8.00K |
|---|
| 2020-06-30 | Reported | (m) | -$8.81M | (m) | $2.71M | (m) | (m) | (m) | $3.18M | $5.08M | $3.25M | $40.00K |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$44.93M | (m) | (m) | (m) | -33.41% | $3.83M | -$15.51M | $31.47M | $38.55M | $112.65M | $66.00K |
|---|
| 2024-12-31 | Reported | -$33.28M | (m) | (m) | (m) | -23.79% | $5.44M | -$16.95M | $40.98M | $34.37M | $101.43M | $50.00K |
|---|
| 2023-12-31 | Reported | -$46.01M | (m) | (m) | (m) | -51.65% | $4.81M | -$41.59M | $35.31M | $29.05M | $74.80M | $20.00K |
|---|
| 2022-12-31 | Reported | -$59.43M | (m) | (m) | (m) | -121.28% | $2.39M | -$58.85M | $27.68M | $25.98M | $58.66M | $9.00K |
|---|
| 2021-12-31 | Reported | -$48.81M | (m) | (m) | (m) | -216.05% | $1.94M | -$44.71M | $18.08M | $24.50M | $32.80M | $8.00K |
|---|
| 2020-12-31 | Reported | -$31.56M | (m) | (m) | (m) | -215.01% | $2.54M | -$35.20M | $12.97M | $21.93M | $15.18M | $57.00K |
|---|